Home › NDC Lookup › RxCUI directory › RxCUI 1992273

Emollient clobetasol propionate 0.5 MG/ML Topical Foam — RxCUI 1992273

RxNorm drug concept · Semantic clinical drug
RxCUI 1992273 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1992273
Official nameEmollient clobetasol propionate 0.5 MG/ML Topical Foam
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asclobetasol propionate 0.05 % Emollient Base Topical Foam
FDA products mapped3
Package NDCs mapped5
Reported Medicaid activity (SDUD)283 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Clobetasol Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Clobetasol propionate shampoo is for moderate to severe scalp psoriasis in adults 18 and older. It is not for use on your face, groin or underarms.
  • Apply a thin film to dry, affected scalp areas once a day. Leave it on for 15 minutes, then lather and rinse well. Wash your hands afterward and keep it away from your eyes and lip...
  • No more than 4 consecutive weeks, and stop sooner if your psoriasis is controlled. If you are not better in 4 weeks, check in with your doctor.
  • Burning, stinging, itching, dryness and acne-like bumps are the most common. Call your doctor if irritation is severe, you see signs of infection, or you notice eye pain or blurred...
📖 Read our full Clobetasol Topical guide →

🕸️ Concept Web — How Emollient clobetasol propionate 0.5 MG/ML Topica... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Emollient clobetasol propionate 0.5 MG/ML Topical Foam RxCUI 1992273

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Clobetasol 2590
    • Clobetasol propionate 21245
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Olux 284814
    • Tovet 2180341
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Clobetasol Topical Foam 379105
    • Clobetasol propionate Topical Foam 2645390
    • Clobetasol Topical Product 1153083
    • Clobetasol propionate Topical Product 2659863
    • Clobetasol Topical Foam [Olux] 370365
    • Clobetasol Topical Foam [Tovet] 2180343
    • Clobetasol propionate Topical Foam [Olux] 2657366
    • Clobetasol propionate Topical Foam [Tovet] 2659028
    • +4 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 21 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Clobetasol propionate 0.5 MG/ML SCDC · 861352
  • Clobetasol Topical Foam SCDF · 379105
  • Clobetasol propionate Topical Foam SCDFP · 2645390
  • Clobetasol Topical Product SCDG · 1153083
  • Clobetasol propionate Topical Product SCDGP · 2659863

Brand-Name Concepts

  • Emollient clobetasol propionate 0.5 MG/ML Topical Foam [Tovet] SBD · 2180345
  • Emollient clobetasol propionate 0.5 MG/ML Topical Foam [Olux] SBD · 1992274
  • Clobetasol propionate 0.5 MG/ML [Olux] SBDC · 861354
  • Clobetasol propionate 0.5 MG/ML [Tovet] SBDC · 2180342
  • Clobetasol Topical Foam [Olux] SBDF · 370365
  • Clobetasol Topical Foam [Tovet] SBDF · 2180343
  • Clobetasol propionate Topical Foam [Olux] SBDFP · 2657366
  • Clobetasol propionate Topical Foam [Tovet] SBDFP · 2659028
  • Olux Topical Product SBDG · 1179893
  • Tovet Topical Product SBDG · 2180344

📦 FDA Products & Package NDCs

3 products · 5 package NDCs
5 package NDCs map to RxCUI 1992273 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
43538-0952-10 1 CANISTER in 1 CARTON (43538-952-10) / 100 g in 1 CANISTER Tovet (emollient formulation) Medimetriks Pharmaceuticals, Inc. 2019-07-31
45802-0637-32 1 CAN in 1 CARTON (45802-637-32) / 50 g in 1 CAN clobetasol propionate emollient formulation Padagis Israel Pharmaceuticals Ltd 2013-02-01
45802-0637-33 1 CAN in 1 CARTON (45802-637-33) / 100 g in 1 CAN clobetasol propionate emollient formulation Padagis Israel Pharmaceuticals Ltd 2013-02-01
68462-0625-27 50 g in 1 CAN (68462-625-27) clobetasol propionate Glenmark Pharmaceuticals Inc., USA 2019-09-09
68462-0625-94 100 g in 1 CAN (68462-625-94) clobetasol propionate Glenmark Pharmaceuticals Inc., USA 2019-09-09
Observed labelers: Glenmark Pharmaceuticals Inc., USA (2) · Padagis Israel Pharmaceuticals Ltd (2) · Medimetriks Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$2.0436
Range $2.0436–$2.4407 · middle 50% $2.0436–$2.4407 · 5 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.